MedPath

Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance)

Phase 4
Completed
Conditions
Hygiene
Registration Number
NCT00497692
Lead Sponsor
Sanofi
Brief Summary

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Femina Delicata.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Phototypes: I, II, III and IV
  • Integral skin test in the region
Exclusion Criteria
  • Pregnancy or breastfeeding women
  • Use of antinflammatory or immune-suppression drugs
  • Personal history of atopy
  • History of sensibilization or irritation for topic products
  • Active cutaneous disease
  • Use of new drugs and/or cosmetics during the study

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Score evaluation of the cutaneous reaction, preconized by International Contact Dermatitis Research Group (ICDRG)six weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sanofi-aventis

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath